[1] Siderowf A, Stern M.Update on Parkinson’s Disease[J]. Ann Intern Med , 2003, 138(8):651-658. [2] Langston JW, Ballard P, Tetrud JW, et al.Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis[J]. Science, 1983, 219:979-980. [3] Yasuhiro I,Yoshihisa K, Yasyuki N.Biphasic effects of MPP+,a possible parkinsonism inducer, on dopamine content and tyrosine hydroxylase mRNA expression in pc12 cell[J]. Neurochem Int, 1995, 26:165-171. [4] Lee ES, Chen H, Charlton CG, et al.The Role of Phospholipid Methylation in 1-Methyl-4-Phenyl-Pyridinium Ion (MPP+)-Induced Neurotoxicity in PC12 Cells[J]. Neuro Toxicology, 2005. 26:945-957. [5] 郑刚, 孟姗姗, 王基野, 等. MPP+对PC12细胞增殖与凋亡的影响[C]. 中国毒理会第五次全国大会论文集, 2009. [6] Dranka BP, Zielonka J, Kanthasamy AG, et al.Bioenergetic Remodeling Induced by 1-methyl 4-phenylpyridinium (MPP+) in Dopaminergic N27 cells: Implications for Parkinson’s Disease[J]. Free Radical Biol Med, 2010, 49:154-155. [ 7] Kook YH, Ka M, Um M. Neuroprotective cytokines repress PUMA induction in the 1-methyl-4-phenylpyridinium (MPP+) model of Parkinson’s disease[J]. Biochem Biophys Res Commun, 2011, 411(2):370-374. [8] 刘扬, 赵咏梅. 6-羟多巴胺诱导帕金森病动物模型的分子作用机制研究进展[J]. 中国老年学杂志, 2005, 25(12):1568-1570. [9] Wang WJ, Song N, Zhang HY, et al.6-Hydroxydopamine upregulates iron regulatory protein 1 by activating certain protein kinase C isoforms in the dopaminergic MES23.5 cell line[J].Int J Biochem Cell B, 2012, 44(11):1987-1992. [10] Jameson GNL, Linert W.Iron release from horse-spleen ferritin by 6-hydroxydopamine: a kinetic study[J].J Inorg Biochem, 1997, 67(14): 164. [11] Blum D, Torch S, Nissou MF.Extracellular toxicity of 6-hydroxydopam-ine on PC12[J]. Neurosci Lett, 2000, 283: 193-196. [12] GlinkaY, Tipton KF, Youdim MB. Mechanism of inhibition ofmito-chondrial respiratory complex I by 6-hydroxydopamine and itsprevention by desferrioxamine[J]. Eur J Pharmaco, 1998, 351(1): 121-129. [13] Schapira AH.Mitochondrial involvement in Parkinson’s disease, Huntingtons’ disease, hereditary spastic paraplegia and Friedreich’s ataxia[J].Biochim BiophysActa, 1999,1410(2): 159-170. [14] Lotharius J, Dugan LL, OM’ alley KL.Distinctmechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons[J]. J Neurosci, 1999, 19(4):1284-1293. [15] Floor E, Wetzel MG.Increased protein oxidation in human sub-stantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay[J]. Neurochem, 1998, 70(1):268-275. [16] Li NY, Ragheb K, Lawler G, et al.Mitochondrial ComplexⅠInhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production[J]. J Biol Chem, 2003, 278(10):8516-8525. [17] Krishnan S,Chi EY,Wood SJ,et a1.Oxidative dimer formation is the critical rate-limiting step for Parkinsen’s disease 〈-synuelein fibrillogenesis[J]. Biochemistry, 2003, 42(3):829-837. [18] Meulener M,Whitworth AJ,Armstrong-Grid CE, et al.Drosephila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson’s disease[J].Curr Biol, 2005, 15(17):1572-1577. [19] Betarbet R, Caner-Aviles RM, Sherer TB, et al. Intersecting pathways to neurodegeneration in Parkinson’s disease: effects of the pesticide rotenone on DJ-1, 〈-synuclein and the ubiquit in-proteasome system[J]. Neurobiol Dis, 2006, 22(2):404-420. [20] Wang C, Ko HS, Thomas B, et al.Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin’s protective function[J]. Hum Mol Genet, 2005, 14(24):3885-3897. [21] Feng J.Microtubule: a common target for parkin and Parkinson’s disease toxins[J]. Neuroscientist, 2006, 12(6):469-476. [22] Hoglinger GU,Carrard G, Michel PP, et al.Dysfunction of mitochondrial complexⅠand the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson’s disease[J]. Neurochem, 2003, 86(5):1297-1307. [23] Hoglinger GU, Lannuzel A,Khondiker ME, et al.The mitochondrial complexⅠinhibitor rotenone triggers a cerebral tauopathy[J].Neurochem, 2005, 95(4):930-939. [24] 杨咏梅. 鱼藤酮对多巴胺能神经元的损伤作用及机制[J].国际病理科学与临床杂志, 2007, 27(2): 145-148. [25] He Y, Imam SZ, Dong Z, et al.Role of nitric oxide in rotenoneinduced nigro-striatal injury[J]. Neurochem, 2003,86(6):1338-1345. [26] Caudle WM, Kitsou E, Li J, et al.A role for a novel protein,nucleolin,in Parkinson’s disease[J]. Neurosci Lett, 2009, 459(1):11-15. [27] Sullivan PG, Dragicevic NB, Deng JH, et al.Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnove r[J]. J BiolChem, 2004, 279(20):20699-20707. [28] 张海娜, 陈秋惠, 韩艳秋, 等. 蛋白酶体抑制剂制备帕金森病模型的研究进展[J]. 山东医药, 2008, 48(37):107-109. [29] Li XP, Du YL, Fan XL, et al.c-Jun N-Terminal Kinase Mediates Lactacystin-Induced Dopamine Neuron Degeneration[J]. J Neuropath Exp Neur, 2008, 67(10): 933-944. [30] 张振涛, 曹学兵, 孙圣刚, 等. 蛋白酶体抑制剂诱导多巴胺能神经元重启细胞周期的作用及机制[J]. 卒中与神经疾病, 2006, 13(3):134-137. [31] 李雁, 殷娟娟, 李昕, 等. 〈-突触核蛋白寡聚体对多巴胺能神经细胞线粒体膜电位的影响[J]. 中国现代神经疾病杂,2008, 8(1):26-31. [32] 张晨, 李昕, 李尧华, 等. 细胞外〈-突触核蛋白对MES23.5多巴胺能神经细胞的促增殖作用[J]. 首都医科大学学报,2006, 27(5):616-619. [33] Stefanis L, Larsen KE, Rideout HJ, et al.Expression of A53T Mutant But Not Wild-Type 〈-Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death[J]. J Neurosci, 2001, 12(24):9549-9560. [34] Mosharov EV, Staal R, Bove J, et al.α-Synuclein Overexpression Increases Cytosolic Catecholamine Concentration[J]. J Neurosci, 2006, 26(36):9304-9311. [35] 鲁玲玲, 梁源, 段春礼, 等. α-synuclein对小剂量鱼藤酮导致的线粒体损伤的调控作用研究[J]. 中国生物工程杂志,2007, 27(12):6-10. [36] Choong CJ, Say YH.Neuroprotection of 〈-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson’s disease mutations A30P, A53T and E46K[J]. NeuroToxicology. 2011, 32(6):857-863. [37] Shafer TJ, Atchison WD.Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies[J]. Neurotoxicology, 1991, 12(3):473-492. [38] Ciccarone V, Spengler BA, Meyers MB, et al.Phenotypic diversification in human neruoblastoma cell: expression of distinct neural crest lineages[J]. Cancer Res, 1989, 49(1):219-225. [39] Shan J, Todorovic M, Wood SA, et al. Parkinson disease derived hons cells are more sensitive to rotenone toxicity than control cells[J]. Parkinsonism Relat D, 2012, 18(2):192. [40] 于鸿, 李尧华, 秀丽, 等. MES23.5细胞酪氨酸羟化酶的种属来源及其重组酶的活性测定[J] . 中国生物化学与分子生物学学报, 2004, 20(1):95-100. [41] Jia W, Xu H, Jiang H, et al.The role of ndfip1 in iron-induced cell damage in MES23.5 dopaminergic cells[J]. Parkinsonism Relat D. 2012, 18(2):196. [42] 张梅英, 蔺美娜, 杨葳, 等. 转染DJ-1和DJ-1L166p基因的NIH3T3细胞中tau基因表达的研究. 实验动物与比较医学, 2008, 28(6):361-366. [43] 韩俊燕, 张晨, 温玫, 等. α-突触核蛋白对MES23.5多巴胺能神经细胞的促增殖作用[J].中国临床康复, 2006, 10(10):104-106. [44] Sung JY, Kim J, Paik SR, et al.Induction of neuronal cell death by Rab5A-dependent endocytosiso of alpha-synuclein[J]. J Biol Chem, 2001, 276(29):27441-27448. [45] Fagerstrom S, Pahlman S, Gestblom C, et al.Protein kinase C-espilon is implicated in neurite outgrowth in differentiating human neuroblastoma cells[J]. Cell Growth Differ, 1996, 7(6):775-785. [46] Fernanda L, Rafael S, Mario J, et al.Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies[J]. Brain Research, 2010,1337:85-94. |